MAYO CLINIC ARIZONA
Project 2: Multi-Omics of high-risk MM
Project 2: Multi-Omics of high-risk MM is a funding opportunity from MAYO CLINIC ARIZONA, up to 370311, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
PROJECT SUMMARY/ABSTRACT While our own extensive studies have confirmed the significant role of the disrupted genome in Multiple Myeloma (MM), they have also re-emphasized the gaps in understanding, and the importance of immune regulation and gene-environment interaction. It is indeed likely that the evolution of MM,…